Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CEBPB-dependent enhancer formation in NRF2-activated non-small cell lung cancer cell line A549 [ChIP-seq]

ABSTRACT: CEBPB was knocked down in A549 cells, and H3K27ac deposition were examined.

ORGANISM(S): Homo sapiens

PROVIDER: GSE186186 | GEO | 2022/10/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

CEBPB-dependent transcriptome in NRF2-activated non-small cell lung cancer cell line A549 [RNA-seq]

Project description:CEBPB was knocked down in A549 cells, and transcriptomic alterations were examined.

2022-10-08 | GSE186187 | GEO

CEBPB-dependent enhancer formation in NRF2-activated non-small cell lung cancer cell line A549 [ChIP-seq]

Project description:CEBPB-dependent enhancer formation in NRF2-activated non-small cell lung cancer cell line A549 [ChIP-seq]

| PRJNA772792 | ENA

CEBPB-dependent transcriptome in NRF2-activated non-small cell lung cancer cell line A549 [RNA-seq]

Project description:CEBPB-dependent transcriptome in NRF2-activated non-small cell lung cancer cell line A549 [RNA-seq]

| PRJNA772793 | ENA

Comparison of gene expression profiles of A549 cell treated with NRF2 siRNA and control siRNA

Project description:To examine the role of NRF2 in accelerating cell proliferation and to identify the target genes responsible for this function, transcriptome analysis was performed using A549 cells, in which NRF2 is constitutively activated. NRF2 was knocked down by siRNA against NRF2, and the gene expression profile was compared with that of A549 cells treated with control siRNA. To exclude off-target effects, three different siRNAs against NRF2 was independently applied. NRF2 siRNA or control siRNA was transfected into A549 cells. Cells were harvested 24 hours after transfection, and total RNA was purified.

2011-04-01 | E-GEOD-28230 | biostudies-arrayexpress

Comparison of gene expression profiles of A549 cell treated with NRF2 siRNA and control siRNA

2011-04-01 | GSE28230 | GEO

Contribution of NRF2 to genome-wide distribution of H3K27ac deposition in A549 cells, a non-small cell lung cancer cell line with KEAP1 mutation

Project description:We report NRF2-dependent and -independent enhancers by comparing H3K27ac deposition in A549 cells with and without NRF2 knockdown.

2020-09-23 | GSE118840 | GEO

Expression profile of human breast cancer cells with CEBPB overexpression

Project description:CEBPB contributes to the migration of breast cancer cells. We used microarrays to detail the mechanism of CEBPB with downstream targets that drive breast cancer cell migration. CEBPB were overexpressed in MDA-MB231 cell for RNA extraction and hybridization on Agilent microarrays. We sought to obtain the mechanisms of CEBPB with downstream proteins that drive breast cancer cell migration.

2015-03-31 | E-GEOD-67425 | biostudies-arrayexpress

ChIP-seq from A549 (ENCSR299ILN)

Project description:CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 1 hours. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-01-10 | GSE91238 | GEO

ChIP-seq from A549 (ENCSR701TCU)

Project description:CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0 hours. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-01-10 | GSE91324 | GEO

ChIP-seq from A549 (ENCSR752AQK)

Project description:CEBPB ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 5 hours. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-01-10 | GSE91330 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data